BOS engages structural-cell circuits largely shared with RAS and fibrotic lung diseases, but along an airway-centered rather than parenchyma-centered axis, and shared structural programs may therefore be targetable across CLAD phenotypes.
Abstract
Background Chronic lung allograft dysfunction (CLAD) is the leading cause of death beyond the first year after lung transplantation, and its most frequent phenotype is bronchiolitis obliterans syndrome (BOS), a fibrotic small-airway disease. Mechanistic work has focused on the immune compartment, yet intensified immunosuppression does not alter established disease. Aim To resolve which structural cell states populate the BOS graft and how they are spatially organized during airway obliteration. Methods We profiled explanted lungs from 33 BOS patients undergoing re-transplantation and 33 controls, combining single-nucleus RNA sequencing (14 BOS, 13 controls) with targeted spatial transcriptomics of 108 regions (27 BOS, 24 controls) and multiplex immunofluorescence validation. Single-nucleus data were integrated with a published restrictive allograft syndrome (RAS) atlas. Results Across 175,128 nuclei and 1.67 million spatially resolved cells, BOS lungs harbored a profibrotic circuit of Aberrant Basaloid cells and CTHRC1+ fibrotic fibroblasts previously described in fibrotic lung diseases, including RAS. Spatial mapping identified a CXCL14+TNC+ injury-associated basal cell state arising early in the obliterative cascade, identifying basal cells as their major reservoir. CTHRC1+ fibroblasts expanded subepithelially replacing resident peribronchial fibroblasts, alongside a peribronchial vascular shift toward systemic venous endothelium. The circuit extended beyond the airway wall to the alveolar interface, defining two convergent remodeling fronts. Conclusion BOS engages structural-cell circuits largely shared with RAS and fibrotic lung diseases, but along an airway-centered rather than parenchyma-centered axis. CLAD thus emerges as a spatial rather than cellular spectrum, defined by anatomical distribution more than cell identity. Shared structural programs may therefore be targetable across CLAD phenotypes.
A potential involvement of vascular remodelling in CLAD pathophysiology is suggested, with changes consistent with pro-inflammatory and fibrogenic processes in CD31+ regions.
Axelle Coppens, Rahel Bodenmann, Janik Riese et al.· American Journal of Transpla...· 1 citation
Background Refractory coeliac disease type 1 (RCD1) lacks defining molecular markers, and the immune and epithelial mechanisms sustaining intestinal injury remain poorly understood. Objective To define the clonal immune and epithelial states that distinguish RCD1 from active coeliac disease (ACD) and determine their sp...
Michael Li, Arman Safavi, J. Samir et al.· bioRxiv· 0 citations
Tracheostomy is a common life-saving procedure, yet recurrent granulation tissue formation at the tracheostomy site remains a challenging clinical problem with unclear mechanisms. Current endoscopic resection offers only temporary relief, and the molecular drivers of persistent fibroproliferation are poorly understood....
Cong Chen, Yu-Hai Dang· Egyptian Journal of Bronchol...· 0 citations
Severe COVID-19 lungs are organized into distinct spatial niches associated with divergent immunopathological trajectories, and imaging-based spatial transcriptomics provides a platform to link histopathological states with localized cellular interactions and macrophage-driven tissue remodeling programs.
Joan Abinet, C. Ruscitti, M. Garigliany et al.· Myeloid Cells· 0 citations
A humanized multi-lineage lung model that captures epithelial-mesenchymal co-development and responsiveness to TGF-β1 stimulation and sensitivity to pirfenidone highlight its potential for antifibrotic drug screening.
Chen-Feng Hua, Chao-Jie Qu, Liu Yang et al.· Frontiers in Cell and Develo...· 0 citations
BACKGROUND
Approximately 10% of individuals who recover from COVID-19 experience residual respiratory symptoms impacting their quality of life, but the mechanisms behind pulmonary long COVID (PLC) are largely unknown.
OBJECTIVES
We characterized airway and circulating immune cells in patients with and without PLC....
E. Guinto, I-Chih Kuo, Sameeksha Chopra et al.· European Respiratory Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.